Jay Moorin, Director, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), bought 1,183,853 shares at $15.00 ($5.0M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market purchase of $5.0M EGRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 850,520 | $0 | 0.0% |
| 2 | $15.00 | 333,333 | $5.0M | 100.0% |
| Total | $4.22 avg | 1,183,853 | $5.0M | 100% |
| Filing → |
| IMDZ | SELL | 2015-04-21 | $1.2M | — | Filing → |
| IMDZ | SELL | 2015-03-18 | $1.3M | — | Filing → |
| ACHN | SELL | 2009-12-18 | $2.0M | — | Filing → |